drugset / Trial / NCT00837369
Regadenoson R-T Perfusion Imaging Trial
Phase 1
Completed
100 enrolled
University of Nebraska
Astellas Pharma Inc · collabMayo Clinic · collab
NaSingle-groupOpen-labelDiagnostic
Summary
To exam the feasibility and accuracy of Regadenoson real time perfusion (RTPE) Imaging during vasodilator stress with Regadenoson for detection of significant coronary artery disease (CAD) in patients scheduled to undergo coronary angiography.
Timeline
- Start
- 2009-04-07
- Primary completion
- 2011-03-01
- Completion
- 2011-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Regadenoson | Diagnostic / imaging agent | 400 ug | Intravenous |